Frontiers in Bioscience, A Journal and Virtual Library
Siamak Tabibzadeh, MD
tabibzadeh at MOFFITT.USF.EDU
Thu Apr 9 07:35:20 EST 1998
This is a multi-part message in MIME format.
------=_NextPart_000_0004_01BD6391.E4A0E7C0
Content-Type: text/plain;
charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
Frontiers in Bioscience
THE BEST BIOSCIENCE HAS TO OFFER
Cited by MEDLINE, Index Medicus,=20
BIOSIS and Chemical Abstracts
=20
Frontiers in Bioscience (FBS) is a virtual journal and =
library bringing the most up-to-date data in life sciences and medicine =
to the desktop of every scientist. FBS offers distinct advantages over =
traditional print journals including a rapid review process, free =
world-wide access, electronic reprint, use of multimedia, and links to =
diverse databases including MEDLINE. FBS is read by over 75,000 readers =
internationally and is accessed over 200,000 times every month in the US =
alone. With its mirror sites, over 700 editors and nearly 100 managing =
editors, FBS is truly an international entity and a valuable platform =
for scientific communication. The virtual library provides numerous =
databases, valuable information as well as forms and links to thousands =
of Web sites of interest to researchers and physicians. Visit this =
scientific treasure on the Web.=20
=20
Team up with distinguished scientists who contribute to FBS:
a.. HIV-1 Nef and host cell protein kinases=20
Kalle Saksela=20
[Vol 2, pp d606-618. December 15, 1997] PubMed =
No: 9388166
a.. Human immunodeficiency virus type I as a target for =
gene therapy=20
Magn=FAs Gottfredsson and Paul R. Bohjanen=20
[Vol 2, pp d619-634, December 15, 1997] PubMed =
No: 9388165
a.. Fibronectin-integrin interactions=20
S. Johansson, G. Svineng, K. Wennerberg, A. =
Armulik and L. Lohikangas
[Vol 2 pp d126-146, March 1, 1997] PubMed No: =
9159220
URLs:
USA: http://www.bioscience.org
Israel: http://bioinfo.weizmann.ac.il/bioscience
France: http://vega.crbm.cnrs-mop.fr/bioscience=20
Frontiers in Bioscience is a non-profit organization =
dedicated to fostering science, education and research
=20
=20
=20
------=_NextPart_000_0004_01BD6391.E4A0E7C0
Content-Type: text/html;
charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
<!DOCTYPE HTML PUBLIC "-//W3C//DTD W3 HTML//EN">
<HTML>
<HEAD>
<META content=3Dtext/html;charset=3Diso-8859-1 =
http-equiv=3DContent-Type>
<META content=3D'"MSHTML 4.72.2106.6"' name=3DGENERATOR>
</HEAD>
<BODY bgColor=3D#ffffff>
<DIV>
<DIV>
<TABLE border=3D1 cellPadding=3D7 cellSpacing=3D4 height=3D975=20
style=3D"HEIGHT: 975px; WIDTH: 569px" width=3D569>
<TBODY>
<TR>
<TD height=3D64 vAlign=3Dtop width=3D20%><FONT size=3D1>
<P><IMG height=3D57 src=3D"Image1.gif" =
width=3D59></FONT></P></TD>
<TD height=3D64 vAlign=3Dtop width=3D80%><FONT=20
face=3D"Old English Text MT,Ribbon131 Bd BT">
<P align=3Dcenter>Frontiers in Bioscience</P></FONT><B><FONT =
size=3D1>
<P align=3Dcenter>THE BEST BIOSCIENCE HAS TO =
OFFER</P></FONT><FONT=20
size=3D1>
<P align=3Dcenter>Cited by MEDLINE, Index Medicus, </P>
<P align=3Dcenter>BIOSIS and Chemical =
Abstracts</B></FONT></P></TD></TR>
<TR>
<TD colSpan=3D2 height=3D146 vAlign=3Dtop><FONT size=3D1>
<P align=3Djustify>Frontiers in Bioscience (FBS) is a =
virtual journal=20
and library bringing the most up-to-date data in life =
sciences and=20
medicine to the desktop of every scientist. FBS offers =
distinct=20
advantages over traditional print journals including a rapid =
review=20
process, free world-wide access, electronic reprint, use of=20
multimedia, and links to diverse databases including =
MEDLINE. FBS is=20
read by over 75,000 readers internationally and is accessed =
over=20
200,000 times every month in the US alone. With its mirror =
sites,=20
over 700 editors and nearly 100 managing editors, FBS is =
truly an=20
international entity and a valuable platform for scientific=20
communication. The virtual library provides numerous =
databases,=20
valuable information as well as forms and links to thousands =
of Web=20
sites of interest to researchers and physicians. Visit this=20
scientific treasure on the Web. </FONT></P></TD></TR>
<TR>
<TD colSpan=3D2 height=3D227 vAlign=3Dtop><FONT size=3D1>
<P align=3Djustify>Team up with distinguished scientists who =
contribute to FBS:</P></FONT><FONT size=3D1>
<P align=3Djustify></P>
<UL><B>
<P align=3Djustify>
<LI>HIV-1 Nef and host cell protein kinases=20
<P></P></LI></UL></B><I>
<P=20
=
align=3Djustify> &nb=
sp; =20
Kalle Saksela </P></I>
<P=20
=
align=3Djustify> &nb=
sp; =20
[Vol 2, pp d606-618. December 15, 1997] PubMed No: =
9388166</P>
<P align=3Djustify></P>
<UL><B>
<P align=3Djustify>
<LI>Human immunodeficiency virus type I as a target for =
gene=20
therapy </B></LI></UL><I>
<P=20
=
align=3Djustify> &nb=
sp; =20
Magnús Gottfredsson and Paul R. Bohjanen </P></I>
<P=20
=
align=3Djustify> &nb=
sp; =20
[Vol 2, pp d619-634, December 15, 1997] PubMed No: =
9388165</P>
<P align=3Djustify></P>
<UL><B>
<P align=3Djustify>
<LI>Fibronectin-integrin interactions=20
<P></P></LI></UL></B><I>
<P=20
=
align=3Djustify> &nb=
sp; =20
S. Johansson, G. Svineng, K. Wennerberg, A. Armulik and L.=20
Lohikangas</P></I>
<P=20
=
align=3Djustify> &nb=
sp; =20
[Vol 2 pp d126-146, March 1, 1997] PubMed No: 9159220</P>
<P align=3Djustify>URLs:</P>
<P align=3Djustify></P>
<DIR>
<DIR><B>
<P>USA:</B> <I>http://www.bioscience.org</P></I><B>
<P>Israel:=20
</B><I>http://bioinfo.weizmann.ac.il/bioscience</P></I><B>
<P>France:</B> http://<I>vega.crbm.cnrs-mop.fr/bioscience =
</P>
<P align=3Dcenter></P></DIR></DIR>
<P align=3Dcenter>Frontiers in Bioscience is a non-profit =
organization=20
dedicated to fostering science, education and=20
research</I></FONT></P></TD></TR></TBODY></TABLE><B><FONT =
size=3D1>
<P></P></B></FONT>
<TABLE border=3D0 cellPadding=3D7 cellSpacing=3D0 width=3D318>
<TBODY>
<TR>
<TD height=3D35 vAlign=3Dtop width=3D6%>
<P></P></TD>
<TD height=3D35 vAlign=3Dtop width=3D94%>
<P></P></TD></TR></TBODY></TABLE><FONT size=3D2>
<P> </P></FONT></DIV></DIV></BODY></HTML>
------=_NextPart_000_0004_01BD6391.E4A0E7C0--
More information about the Bioforum
mailing list